Explore our clinical data
REAL-WORLD DATA
ALIGN-AF prospective real-world registry
ALIGN-AF is a prospective real-world registry within the DISRUPT-AF registry, evaluating real-world outcomes of combined AFib ablation and left atrial appendage (LAA) closure with the FARAWAVE PFA Catheter and WATCHMAN FLX Pro Device.
Real-world results demonstrated a strong safety profile and high LAA closure, supporting FARAWATCH™ as a practical approach for AFib patients eligible for both.
- 100% procedural success
- 90.6% complete seal (0 mm) at 45 days
- 94.1% patients showed no new LAA edema after FARAWAVE ablation
Learn more about the WATCHMAN™ Device Platform, the most studied and most implanted left atrial appendage closure device. Backed by decades of clinical research and real-world experience, WATCHMAN has established a legacy of proven outcomes across pivotal trials, long-term follow-up studies, and large-scale registries, helping define the standard of care in LAAC therapy.
Learn more about the FARAPULSE™ PFA Platform with the largest and most comprehensive clinical evidence base in pulsed field ablation, with unmatched volume in peer-reviewed studies, registry participation, and patient outcomes across pivotal trials and real-world registries.*1-3
Peer Perspectives: Case Insights
Clinicians highlight workflow best practices, clinical evidence, and patient benefit of combining FARAPULSE PFA and WATCHMAN FLX Pro procedures in one streamlined case.
FARAWATCH Resources
Find the resources you need to support your practice, increase efficiencies, improve patient outcomes, and transform a concomitant procedure into a more complete model of AFib care.
*Studied in over 70,700 patients
References
- BSC data on file.
- Listing of publications and clinical trials on file at BSC.
- Additional publications by Turagam, Mohit., et al., Ekanem, Emmanuel, et al., Chaumont, Corentin, et al., Wong, Elisabeth, et al., Boersma, Lucas VA, et al., Mills, Mark T., et al., Bisignani, Antonio, et al.